Dow Up 0.36% Nasdaq Up 0.12%

Intra-Cellular Therapies, Inc. (ITCI)

-NasdaqGS
14.97 Down 0.58(3.73%) 4:00PM EDT
Prev Close:15.55
Open:15.51
Bid:14.95 x 700
Ask:14.97 x 1900
1y Target Est:29.33
Beta:N/A
Next Earnings Date:N/A
Day's Range:14.52 - 15.55
52wk Range:13.26 - 21.26
Volume:69,367
Avg Vol (3m):105,923
Market Cap:439.91M
P/E (ttm):N/A
EPS (ttm):-1.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ITCI

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):242.74
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.01
Quarterly EPS Est (Sep-14) :-0.28
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the central nervous system (CNS). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback